中华眼底病杂志
中華眼底病雜誌
중화안저병잡지
CHINESE JOURNAL OF OCULAR FUNDUS DISEASES
2010年
4期
328-330
,共3页
王家伟%邓娟%戚朝秀%陈秋燕%杨渝
王傢偉%鄧娟%慼朝秀%陳鞦燕%楊渝
왕가위%산연%척조수%진추연%양투
视神经疾病/病因学%多发性硬化/诊断%多发性硬化/治疗%视神经脊髓炎/诊断%视神经脊髓炎/治疗
視神經疾病/病因學%多髮性硬化/診斷%多髮性硬化/治療%視神經脊髓炎/診斷%視神經脊髓炎/治療
시신경질병/병인학%다발성경화/진단%다발성경화/치료%시신경척수염/진단%시신경척수염/치료
Optic nerve diseases/etiology,Multiple sclerosis/diagnosis%Multiple sclerosis/therapy%Neuromyelitis optica/diagnosis%Neuromyelitis optica/therapy
目的 观察伴有眼部异常的多发性硬化(MS)及视神经脊髓炎(NMO)患者的眼部特征及治疗效果.方法 回顾分析我院确诊为MS及NMO且伴有眼部异常的107例患者的临床资料.其中,MS患者81例,NMO患者26例.所有患者均接受MRI、腰椎穿刺脑脊液(CSF)检测红、白细胞计数、蛋白含量及寡克隆带,确定MS及NMO临床诊断.对所有患者行视力、裂隙灯显微镜、眼底等常规眼科检查,并行计算机视野和视觉诱发电位(VEP)检查,对比分析MS、MMO患者眼部临床特征的异同.对患者进行大剂量甲泼尼龙冲击治疗或中药活血化瘀、营养神经治疗后,分析不同治疗方法对眼部症状改善的影响.所有患者随访1个月~5年,平均随访时间26个月.结果 MS患者中球后视神经炎24例,占MS患者总数的29.6%;麻痹性斜视和复视36例,占44.4%.NMO患者中急性视盘炎12例,占NMO患者总数的46.2%;球后视神经炎14例,占53.8%.MS和NMO患者视野检查异常率分别为71.6%、96.2%.MRI检查结果显示MS患者脱髓鞘斑块位于脑室旁最常见;NMO患者病灶多累及脊髓.脑脊液检查结果显示MS患者寡克隆带阳性率为75.3%,NMO患者为19.2%.MS和NMO患者VEP检查主要表现为P100波潜伏期延长和(或)波幅降低.接受甲泼尼龙冲击治疗与未接受冲击治疗的患者视力提高率分别为84.7%、80.0%,差异无统计学意义(χ2=0.221,P>0.05).结论 MS及NMO患者均可能发生视神经炎.糖皮质激素冲击治疗可加速患者眼部症状的改善.
目的 觀察伴有眼部異常的多髮性硬化(MS)及視神經脊髓炎(NMO)患者的眼部特徵及治療效果.方法 迴顧分析我院確診為MS及NMO且伴有眼部異常的107例患者的臨床資料.其中,MS患者81例,NMO患者26例.所有患者均接受MRI、腰椎穿刺腦脊液(CSF)檢測紅、白細胞計數、蛋白含量及寡剋隆帶,確定MS及NMO臨床診斷.對所有患者行視力、裂隙燈顯微鏡、眼底等常規眼科檢查,併行計算機視野和視覺誘髮電位(VEP)檢查,對比分析MS、MMO患者眼部臨床特徵的異同.對患者進行大劑量甲潑尼龍遲擊治療或中藥活血化瘀、營養神經治療後,分析不同治療方法對眼部癥狀改善的影響.所有患者隨訪1箇月~5年,平均隨訪時間26箇月.結果 MS患者中毬後視神經炎24例,佔MS患者總數的29.6%;痳痺性斜視和複視36例,佔44.4%.NMO患者中急性視盤炎12例,佔NMO患者總數的46.2%;毬後視神經炎14例,佔53.8%.MS和NMO患者視野檢查異常率分彆為71.6%、96.2%.MRI檢查結果顯示MS患者脫髓鞘斑塊位于腦室徬最常見;NMO患者病竈多纍及脊髓.腦脊液檢查結果顯示MS患者寡剋隆帶暘性率為75.3%,NMO患者為19.2%.MS和NMO患者VEP檢查主要錶現為P100波潛伏期延長和(或)波幅降低.接受甲潑尼龍遲擊治療與未接受遲擊治療的患者視力提高率分彆為84.7%、80.0%,差異無統計學意義(χ2=0.221,P>0.05).結論 MS及NMO患者均可能髮生視神經炎.糖皮質激素遲擊治療可加速患者眼部癥狀的改善.
목적 관찰반유안부이상적다발성경화(MS)급시신경척수염(NMO)환자적안부특정급치료효과.방법 회고분석아원학진위MS급NMO차반유안부이상적107례환자적림상자료.기중,MS환자81례,NMO환자26례.소유환자균접수MRI、요추천자뇌척액(CSF)검측홍、백세포계수、단백함량급과극륭대,학정MS급NMO림상진단.대소유환자행시력、렬극등현미경、안저등상규안과검사,병행계산궤시야화시각유발전위(VEP)검사,대비분석MS、MMO환자안부림상특정적이동.대환자진행대제량갑발니룡충격치료혹중약활혈화어、영양신경치료후,분석불동치료방법대안부증상개선적영향.소유환자수방1개월~5년,평균수방시간26개월.결과 MS환자중구후시신경염24례,점MS환자총수적29.6%;마비성사시화복시36례,점44.4%.NMO환자중급성시반염12례,점NMO환자총수적46.2%;구후시신경염14례,점53.8%.MS화NMO환자시야검사이상솔분별위71.6%、96.2%.MRI검사결과현시MS환자탈수초반괴위우뇌실방최상견;NMO환자병조다루급척수.뇌척액검사결과현시MS환자과극륭대양성솔위75.3%,NMO환자위19.2%.MS화NMO환자VEP검사주요표현위P100파잠복기연장화(혹)파폭강저.접수갑발니룡충격치료여미접수충격치료적환자시력제고솔분별위84.7%、80.0%,차이무통계학의의(χ2=0.221,P>0.05).결론 MS급NMO환자균가능발생시신경염.당피질격소충격치료가가속환자안부증상적개선.
Objective To observe the ocular manifestations and therapeutic effect of multiple sclerosis (MS) and neuromyelitis optica (NMO) with ocular symptoms. Methods The clinical data of 107 patients who was diagnosed with MS and NMO with ocular symptoms in our hospital were retrospectively analyzed, including 81 MS patients and 26 NMO patients. The counting of erythocytes and leukocyte, protein content and oligoclonal bands were detected by MRI and cerebrospinal fluid (CSF) in order to ensure the clinical diagnosis with MS and NMO. All the patients had undergone regular ophthalmologic examination of visual acuity,slit lamp microscope and fundus examination. In addition, visual field and visual evoked potential (VEP) examination were performed to analyze the clinical characteristics of ocular manifestations. The patients were received therapy with large dose methyl-prednisolone or activating blood and dissolving stasis and trophic nerve by Chinese medicine. The effects of three methods on ocular manifestations were analyzed. All the patients were followed up for one month to five years. Results Among 81 MS patients,retrobulbar neuritis occurred in 24 patients (29. 6%), the other common symptoms included paralytic strabismus and diplopia(30.3%). Among 26 NMO patients, acute papillitis occurred in 12 (46. 2%), while retrobulbar neuritis occurred in 14 (53. 8%). The most common symptom of both MS and NMO was impaired vision and high abnormal rate. The results of MRI showed that demyelinating lesions beside ventricle was the most performance in MS patients,while abnormalities in spinal cord were found in NMO patients. The results of CSF showed that the positive oligoclonal bands was 75.3% and 19.2% in MS and NMO patients respectively. The potential time delay and (or) amplitude declination were observed by VEP. Large dose methyl-prednisolone can improve vision and diplopia in a short period. Conclusion The abnormal ocular manifestations of MS and NMO patients are common and complicated. Ocular symptoms has important reference value in the early diagnosis of MS and NMO.